This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Source text - English Problem: Women with BRCA1 or BRCA2 mutations are at significantly elevated risk for developing breast or ovarian cancer, but testing all women for these genetic mutations is expensive and ill-advised. In addition, well-known models can help identify women at risk for sporadic cancers, but only if enough personal information is collected by her physician. Identifying women with an increased risk of developing breast or ovarian cancer is a difficult and time-consuming process.
Translation - French Le problème : Les femmes présentant une mutation des gènes BRCA1 ou BRCA2 courent un risque accru de développer un cancer du sein ou des ovaires ; mais un dépistage systématique de toutes les femmes pour chercher la présence de ces gènes serait coûteux et peu judicieux. Par ailleurs, des modèles bien connus peuvent aider à identifier les femmes susceptibles de développer un cancer sporadique, mais seulement si une information personnelle suffisante est recueillie par le médecin. Identifier les femmes à risque accru de développer un cancer des ovaires ou du sein est une tâche difficile et fastidieuse.
More
Less
Experience
Years of experience: 57. Registered at ProZ.com: Jul 2006.
